Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions*

The flavivirus West Nile virus (WNV) has spread rapidly throughout the world in recent years causing fever, meningitis, encephalitis, and fatalities. Because the viral protease NS2B/NS3 is essential for replication, it is attracting attention as a potential therapeutic target, although there are currently no antiviral inhibitors for any flavivirus. This paper focuses on elucidating interactions between a hexapeptide substrate (Ac-KPGLKR-p-nitroanilide) and residues at S1 and S2 in the active site of WNV protease by comparing the catalytic activities of selected mutant recombinant proteases in vitro. Homology modeling enabled the predictions of key mutations in WNV NS3 protease at S1 (V115A/F, D129A/E/N, S135A, Y150A/F, S160A, and S163A) and S2 (N152A) that might influence substrate recognition and catalytic efficiency. Key conclusions are that the substrate P1 Arg strongly interacts with S1 residues Asp-129, Tyr-150, and Ser-163 and, to a lesser extent, Ser-160, and P2 Lys makes an essential interaction with Asn-152 at S2. The inferred substrate-enzyme interactions provide a basis for rational protease inhibitor design and optimization. High sequence conservation within flavivirus proteases means that this study may also be relevant to design of protease inhibitors for other flavivirus proteases.

[1]  M. Murcko,et al.  Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide , 1996, Cell.

[2]  B. Falgout,et al.  Mutagenesis of the NS3 Protease of Dengue Virus Type 2 , 1998, Journal of Virology.

[3]  E. Gould,et al.  Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. , 2003, The Journal of general virology.

[4]  M. Lobigs.  Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Parge,et al.  The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor. , 1998, Clinical and diagnostic virology.

[6]  C. Rice,et al.  Flavivirus genome organization, expression, and replication. , 1990, Annual review of microbiology.

[7]  C. Rice,et al.  Mutagenesis of the yellow fever virus NS2B/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication , 1995, Journal of virology.

[8]  D. Fairlie,et al.  An efficient Fmoc strategy for the rapid synthesis of peptide para-nitroanilides , 2000, Letters in Peptide Science.

[9]  C. Rice,et al.  Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. , 1993, Virology.

[10]  M. Brinton.  The molecular biology of West Nile Virus: a new invader of the western hemisphere. , 2002, Annual review of microbiology.

[11]  R. Padmanabhan,et al.  The Serine Protease and RNA-Stimulated Nucleoside Triphosphatase and RNA Helicase Functional Domains of Dengue Virus Type 2 NS3 Converge within a Region of 20 Amino Acids , 1999, Journal of Virology.

[12]  N. Pattabiraman,et al.  All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach. , 1996, Journal of medicinal chemistry.

[13]  D. Fairlie,et al.  Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing. , 2000, Journal of medicinal chemistry.

[14]  W. Rutter,et al.  Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. , 1987, Biochemistry.

[15]  Michael W. Parker,et al.  Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. , 1999, Science.

[16]  K. Wüthrich.  NMR of proteins and nucleic acids , 1988 .

[17]  C. Rice,et al.  Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. , 1994, Virology.

[18]  L. DeLucas,et al.  Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design. , 2000, Journal of molecular biology.

[19]  Martin J. Stoermer,et al.  Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors* , 2001, The Journal of Biological Chemistry.

[20]  Martin J. Stoermer,et al.  Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease* , 2004, Journal of Biological Chemistry.

[21]  R. Padmanabhan,et al.  Dengue Virus NS3 Serine Protease , 1999, The Journal of Biological Chemistry.

[22]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[23]  R. Miller,et al.  Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity , 1993, Journal of virology.

[24]  H. Guzmán,et al.  Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model , 2002, Emerging infectious diseases.

[25]  C. Hayes.  West Nile Virus: Uganda, 1937, to New York City, 1999 , 2001, Annals of the New York Academy of Sciences.

[26]  R J Fletterick,et al.  Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Fairlie,et al.  Protease inhibitors: current status and future prospects. , 2000, Journal of medicinal chemistry.

[28]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[29]  R. Fletterick,et al.  Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. , 1989, Virology.

[30]  D. A. Nichols,et al.  Comparison of the conformation and electrostatic surface properties of magainin peptides bound to sodium dodecyl sulfate and dodecylphosphocholine micelles , 2003, Biopolymers.

[31]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[32]  C. Rice,et al.  Mutagenesis of the NS2B-NS3-Mediated Cleavage Site in the Flavivirus Capsid Protein Demonstrates a Requirement for Coordinated Processing , 1999, Journal of Virology.

[33]  G. Wengler,et al.  The carboxy-terminal part of the NS 3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. , 1991, Virology.

[34]  V. Blinov,et al.  N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. , 1989, Nucleic acids research.

[35]  D. Fairlie,et al.  Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. , 1999, The Journal of general virology.

[36]  K E Ebner,et al.  Cotranslational Membrane Insertion of the Serine Proteinase Precursor NS2B-NS3(Pro) of Dengue Virus Type 2 Is Required for Efficient in Vitro Processing and Is Mediated through the Hydrophobic Regions of NS2B* , 1997, The Journal of Biological Chemistry.